Is AtriCure, Inc. (ATRC) a Buy, Sell, or Hold?
NASDAQ : ATRC
AtriCure, Inc. — Analyst Ratings
$39.34 USD
$0.34 (0.87%)
- Volume
- 742.87K
- Average Volume
- 1.11M
- Market Capitalization
- $2B
- P/E Ratio
- 185.39
- Dividend Yield
- 0.00%
- Price Target
- $51.00
- Year High
- $43.18
- Year Low
- $25.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.22
Analyst Consensus Summary
Consensus Rating
Neutral
19 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-22.9%
vs Current Price
Price Target
$51.00
Average TargetPrice Target Range
Lowest Target
$44.00
-10.6% DOWNSIDE
Average Target
$51.00
Median Estimate
Highest Target
$55.00
-28.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 19
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 18 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | William Plovanic | $53 | $32.97 | 2026-02-18 07:02 AM | 60.8% |
| Canaccord Genuity | William Plovanic | $64 | $35.44 | 2025-10-30 06:27 AM | 80.6% |
| Stifel Nicolaus | Rick Wise | $26 | $22 | 2024-07-31 02:57 AM | 18.2% |
| Piper Sandler | Matt O'Brien | $40 | $22 | 2024-07-31 02:51 AM | 81.8% |